These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 25762155)
1. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS. Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155 [TBL] [Abstract][Full Text] [Related]
2. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis. Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900 [TBL] [Abstract][Full Text] [Related]
3. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis. Lin PY; Simon SM; Koh WK; Folorunso O; Umbaugh CS; Pierce A Mol Neurodegener; 2013 Nov; 8():43. PubMed ID: 24256636 [TBL] [Abstract][Full Text] [Related]
4. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS. Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731 [TBL] [Abstract][Full Text] [Related]
5. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis. Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1. Tokuda E; Okawa E; Watanabe S; Ono S Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136 [TBL] [Abstract][Full Text] [Related]
8. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1 Mitsui S; Otomo A; Nozaki M; Ono S; Sato K; Shirakawa R; Adachi H; Aoki M; Sobue G; Shang HF; Hadano S Mol Brain; 2018 May; 11(1):30. PubMed ID: 29843805 [TBL] [Abstract][Full Text] [Related]
9. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389 [TBL] [Abstract][Full Text] [Related]
10. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. Lelie HL; Liba A; Bourassa MW; Chattopadhyay M; Chan PK; Gralla EB; Miller LM; Borchelt DR; Valentine JS; Whitelegge JP J Biol Chem; 2011 Jan; 286(4):2795-806. PubMed ID: 21068388 [TBL] [Abstract][Full Text] [Related]
11. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702 [TBL] [Abstract][Full Text] [Related]
12. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice. Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926 [TBL] [Abstract][Full Text] [Related]
13. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. Nagai M; Aoki M; Miyoshi I; Kato M; Pasinelli P; Kasai N; Brown RH; Itoyama Y J Neurosci; 2001 Dec; 21(23):9246-54. PubMed ID: 11717358 [TBL] [Abstract][Full Text] [Related]
14. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Koyama S; Arawaka S; Chang-Hong R; Wada M; Kawanami T; Kurita K; Kato M; Nagai M; Aoki M; Itoyama Y; Sobue G; Chan PH; Kato T Biochem Biophys Res Commun; 2006 May; 343(3):719-30. PubMed ID: 16563356 [TBL] [Abstract][Full Text] [Related]
15. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Turner BJ; Talbot K Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652 [TBL] [Abstract][Full Text] [Related]
16. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261 [TBL] [Abstract][Full Text] [Related]
17. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140 [TBL] [Abstract][Full Text] [Related]
18. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. Urushitani M; Kurisu J; Tsukita K; Takahashi R J Neurochem; 2002 Dec; 83(5):1030-42. PubMed ID: 12437574 [TBL] [Abstract][Full Text] [Related]
19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network. Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]